Previous studies have shown that cPLA2 is overexpressed in the vessels of advanced-stage cardiovascular disease patients; it has emerged as a novel therapeutic target to prevent vascular calcification in CVD [64]. Here, PLA2G4A is linked to cardiovascular disorder.